ETFiShares Nasdaq BiotechnologyIBB

IBB

iShares Nasdaq Biotechnology

132.75 -1.89 (-1.40%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
S
132.75
B
133.04
Top
Amin Harirchian
$RETA (Reata Pharmaceuticals Inc) - Update 𝙒𝙝𝙮 𝙨𝙪𝙘𝙝 𝙖 𝙗𝙞𝙜 𝙙𝙧𝙤𝙥❓ Reata Pharmaceuticals has had a meeting with the US Food Drug Administration (FDA) regarding Omaveloxelone (Omav) for the treatment of Friedreich’s ataxia (FA). The purpose of this meeting was for the FDA to provide Reata... Show More
Like CommentShare
1 reply
null
.